Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation

Homology Medicines, Inc. (FIXX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 4 Jordan Julie (Chief Medical Officer) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 436 shares @ $1.39, valued at $606
Sold 109 shares @ $1.39, valued at $151.5
Sold 1,308 shares @ $1.39, valued at $1.8k
Exercised 1,548 restricted stock units @ $0
Exercised 387 restricted stock units @ $0
Exercised 4,644 restricted stock units @ $0
08/04/2023 4 Jordan Julie (Chief Medical Officer) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 99 shares @ $1.31, valued at $129.7
Exercised 350 restricted stock units @ $0
06/15/2023 4 GILLIS STEVEN (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $1.03, valued at $23.7k
06/15/2023 4 Patterson Matthew R (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $1.03, valued at $23.7k
06/15/2023 4 Thistle Mary (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $1.03, valued at $23.7k
06/15/2023 4 TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $1.03, valued at $23.7k
06/15/2023 4 Poulton Jeffrey V. (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $1.03, valued at $23.7k
06/15/2023 4 REICIN ALISE (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $1.03, valued at $23.7k
03/16/2023 3 Jordan Julie (Chief Medical Officer) has filed a Form 3 on Homology Medicines, Inc.
03/06/2023 4 Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 10,965 shares @ $1.4467, valued at $15.9k
02/27/2023 4 Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 164,000 options to buy @ $1.6, valued at $262.4k
Granted 27,000 restricted stock units @ $0
02/27/2023 4 Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 104,000 options to buy @ $1.6, valued at $166.4k
Granted 17,000 restricted stock units @ $0
02/27/2023 4 Smith W Bradford (See remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 213,000 options to buy @ $1.6, valued at $340.8k
Granted 36,000 restricted stock units @ $0
02/27/2023 4 Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 632,000 options to buy @ $1.6, valued at $1M
Granted 105,000 restricted stock units @ $0
01/20/2023 3/A Blum Michael Lee (Chief Commercial Officer) has filed a Form 3/A on Homology Medicines, Inc.
01/20/2023 4/A Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.
01/20/2023 4/A Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
01/20/2023 4/A Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
01/11/2023 4 Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 2,454 shares @ $1.3904, valued at $3.4k
01/11/2023 4 Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 3,090 shares @ $1.3903, valued at $4.3k
01/11/2023 4 Smith W Bradford (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 3,729 shares @ $1.3912, valued at $5.2k
01/11/2023 4 Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 3,620 shares @ $1.3904, valued at $5k
01/11/2023 4 TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Sold 10,616 shares @ $1.3905, valued at $14.8k
01/04/2023 4 Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.
Txns: Exercised 2,640 restricted stock units @ $0
Exercised 4,950 restricted stock units @ $0
01/04/2023 4 TZIANABOS ARTHUR (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Exercised 13,860 restricted stock units @ $0
Exercised 19,140 restricted stock units @ $0
01/04/2023 4 Seymour Albert (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Exercised 4,290 restricted stock units @ $0
Exercised 6,930 restricted stock units @ $0
01/04/2023 4 Smith W Bradford (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Exercised 6,600 restricted stock units @ $0
Exercised 6,930 restricted stock units @ $0
01/04/2023 4 Alloway Paul (See Remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Exercised 4,290 restricted stock units @ $0
Exercised 5,280 restricted stock units @ $0
09/08/2022 4 Seymour Albert (See remarks) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 23,000 options to buy @ $2.18, valued at $50.1k
Granted 14,000 restricted stock units @ $0
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 REICIN ALISE (Director) has filed a Form 4 on Homology Medicines, Inc.
Txns: Granted 18,000 options to buy @ $1.88, valued at $33.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy